Simplicity Solutions’s MacroGenics MGNX Stock Holding History

Simplicity Solutions’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,545	Closed	-$358K	–	381
2015 Q4	$358K	Buy	+11,545	New	+$351K	0.04%	513

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Simplicity Solutions's MGNX Position: Q1 2016 in Review

Simplicity Solutions sold out of MacroGenics (MGNX) in Q1 2016, closing a stake of 11,545 shares — an estimated $358K sold.

Simplicity Solutions first reported a position in MGNX in Q4 2015 and held it in 1 quarter. The position peaked at $358K in Q4 2015. 126 funds tracked by Wall St. Rank hold MGNX as of Q1 2016.

Simplicity Solutions reported no remaining MacroGenics position as of Q1 2016 after selling out during the quarter.
Simplicity Solutions sold 11,545 MacroGenics shares in Q1 2016, an estimated $358K.
Simplicity Solutions first reported a position in MacroGenics in Q4 2015 and held it in 1 quarter.
Simplicity Solutions's MacroGenics position peaked at $358K in Q4 2015.
126 funds tracked by Wall St. Rank held MacroGenics as of Q1 2016.

Based on Simplicity Solutions's 13F filing for Q1 2016, filed 26 Apr 2016.